Company intelligence / Profile preview

Allergen Servilab

Madrid, Madrid, Spainallergenservilab.com ↗

Ownership: Private
Development stage: Other

Overview

Allergen Servilab is a Spanish biotechnology company specializing in the diagnosis and treatment of allergic diseases. The company develops and manufactures a wide range of allergen immunotherapy products, including subcutaneous and sublingual vaccines tailored to specific patient sensitivities. Their portfolio also includes diagnostic tools such as skin prick tests and in vitro diagnostic reagents for identifying environmental and food allergens. Allergen Servilab focuses on providing personalized medicine solutions to improve the quality of life for patients suffering from respiratory and venom-related allergies.

Therapeutic areas: Immunology
Modalities: BiologicVaccinePeptides
Industry: Biotech

Beyond the preview

Go deeper on Allergen Servilab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allergen Servilab.

Explore the full profile